A 2026 paper examined MOTS-c in an experimental type-2-diabetes rat model. The researchers measured metabolic and inflammatory responses, including markers associated with inflammasome activity in cardiac tissue.
The useful distinction is between observing specified markers in a particular animal model and establishing an outcome in people. The model, disease induction and measured endpoints constrain the conclusion. This paper does not establish a general claim about a commercially supplied material.
Read the original abstract for the experimental context. Our compound reference connects this topic with earlier MOTS-c work on metabolic signaling and stress responses.
Sources & reading notes
- Mitochondrial peptide MOTS-c suppresses systemic and cardiac inflammasome activation in a diabetic rat modelSource access: abstract / bibliographic record.
Original editorial summary based on the linked record. Not a complete literature search. Scientific review pending.